An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
Levamisole has been studied across 17 research domains including 🔬 Oncology, 🛡️ Immunity, ✨ Skin & Hair, 🧠 Focus & Attention, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 17% of studies addressing this area.
The following compounds share molecular targets with Levamisole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Levamisole is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.